Compositions and Methods for Enhancing AAV Therapy and Decreasing Tropism of AAV to the Liver
AssigneeVertex Pharmaceuticals Incorporated
InventorsGregoriy Aleksandrovich Dokshin, Jishnu Saha
Life of this patent
Estimating the term…
Abstract
Compositions and methods for enhancing AAV therapy by increasing the percentage of AAV delivered to a non-liver target in a subject by blocking binding of binding of AAVs to AAV receptors in the liver and then administering an AAV therapy targeting a non-liver tissue.
Claims43
A composition comprising an agent that blocks AAV binding to an AAV receptor (AAVR) and a delivery molecule that delivers the agent to the liver.
-8. (canceled)
(canceled)
(canceled)
A method comprising:
- (a) administering to a subject an agent that blocks AAV binding to an AAV receptor (AAVR) in the liver, and then (b) administering an AAV vector to the subject.
(canceled)
(canceled)
A method of increasing the percentage of AAV delivered to a non-liver target in a subject, comprising (a) a pre-conditioning step comprising administering to the subject a composition comprising an agent that blocks AAV binding to an AAV receptor (AAVR) in the liver, and then (b) administering an AAV vector targeting a non-liver tissue.
-25. (canceled)
(canceled)
-32. (canceled)
-41. (canceled)
(canceled)
(canceled)
(canceled)
-56. (canceled)
-60. (canceled)
(canceled)
Dependencies are inferred from the claim text.